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Background: For patients with acute coronary syndrome, percutaneous coronary intervention (PCI) can be life saving. In contrast, for patients 
with chronic stable angina the benefits of PCI are limited to symptom relief. Following the highly-publicized COURAGE trial, we hypothesized that few 
cardiologists would believe that PCI reduced major cardiac events in stable angina, but that the majority of patients would continue to believe that 
it does.
Methods: Between December 1, 2007 and August 31, 2008, we surveyed patients who had already consented to elective catheterization and 
possible PCI about their beliefs regarding the benefits of PCI. We also surveyed the patients’ cardiologists using an abbreviated form of patient 
survey.
Results: Of 164 patients approached, 153 (93%) agreed to participate in the survey. In the survey, 88% believed that PCI would reduce their risk of 
MI and 82% thought it would reduce their risk of death. Few patient characteristics were associated with patient beliefs. 53% of patient (n=86) had 
no chest pain or had chest pain less than once per week. All underwent catheterization, but only 53 patients received PCI. The most common reason 
for PCI was positive stress test (67%). Ten of 11 interventional cardiologists completed surveys. Of the patients who underwent PCI, 85% thought 
PCI would reduce the risk of MI and 76% thought it would reduce mortality. Cardiologists believed that the benefit in most cases was angina relief 
(94%), but in a few believed it would prevent MI (17%) or death (15%). There was little or no correlation between the beliefs of cardiologists and 
patients regarding prevention of MI (κ=0.08) or mortality (κ= -0.04). Compared to the cardiologists’ perceptions, patients were less likely to report 
having any angina (75% vs. 98%, p=0.03). Patients also believed they were more likely to have a heart attack (median response 3 vs. 2 on a 5 point 
Likert scale, p=0.02).
Conclusion: The COURAGE trial appears to have convinced cardiologists that PCI does not reduce mortality in stable coronary disease, but this 
message has not reached patients. More research is needed on how to best communicate the medical evidence so that patients can make informed 
decisions.
